Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliance Certificate Pursuant To Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2023

Dear Sir/Madam, Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Compliance Certificate for the year ended March 31, 2023 duly signed by the Compliance Officer of the Company and the authorized representative of the Share Transfer Agent viz. M/s. Link Intime India Private Limited, certifying compliance with the requirements of Regulation 7(2) of the said Regulations. Kindly take the same on your record.
10-04-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st March, 2023, as received from Link Intime India Pvt. Ltd, the Registrar and Share Transfer Agent (RTA) of the Company.
10-04-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Closure of Trading Window

Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the code of Prohibition of Insider Trading adopted by Company, the trading window for dealing in securities of the company will remain closed from April 01, 2023, till 48 hours after declaration of Financial Results of the Company for the quarter and year ended March 31, 2023.
30-03-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Postal Ballot-Voting Results And Scrutinizer''s Report

Pursuant to regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) 2015, the voting results of the Postal Ballot is enclosed along with Scrutinizer''''s Report pursuant to Section 108 & 110 of the Companies Act, 2013 read with Rule 20 & 21 of the Companies (Management and Administration) Rules, 2014. Kindly take the same on your records.
24-03-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith newspaper advertisement(s) published today i.e. February 22, 2023 in Business Standard (English Edition) and Mumbai Lakshadeep (Marathi Edition), with respect to completion of dispatch of Postal Ballot Notice dated February 14, 2023, electronically, to the Shareholders of the Company.
22-02-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

It is hereby informed that approval of members is sought by way of Postal Ballot on the agenda items listed in the Postal Ballot Notice dated February 14, 2023. The Company has completed the dispatch of Postal Ballot Notice in electronic form only as permitted under the MCA & SEBI Circulars. In compliance with Sections 108 and 110 of the Companies Act, 2013 read with the rules framed there under and the MCA & SEBI Circulars, the Company has extended only remote e-voting facility for its members, to enable them to cast their votes electronically instead of submitting the postal ballot form. In this regard, the Company has engaged the services of NSDL for providing e-voting facility. The E-voting period will commence on February 22, 2023 at 09.00 a.m. and would end on March 23, 2023 at 5.00 p.m. The result of postal ballot will be announced on or before March 25, 2023. This is for your information and record.
20-02-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Un-Audited Financial Results For The Quarter Ended December 31, 2022.

Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), this is to inform that Board of Directors of the Company, in their meeting held today i.e. February 14, 2023 has inter-alia considered and approved the un-audited Financial Results for the quarter and nine months ended on December 31, 2022.
14-02-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting Held On February 14, 2023

Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (''''Listing Regulations''''), the Board of Directors of the Company at their held on Tuesday, 14th February, 2023 which was commenced at 03:30 P.M. and concluded at 04:05 PM. Attached Agenda items were approved in the meeting.
14-02-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Board Meeting Intimation for The Meeting Of Board Of Directors Of The Company To Be Held On 14Th February, 2023

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 ,inter alia, to consider and approve the unaudited financial results for the quarter ended 31st December, 2022 and other business matters.
06-02-2023
Bigul

Aspira Pathlab & Diagnostics Ltd - 540788 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, for the quarter ended 31st December, 2022, as received from Link Intime India Pvt. Ltd, the Registrar and Share Transfer Agent (RTA) of the Company.
10-01-2023
Next Page
Close

Let's Open Free Demat Account